Sangwoon Lee
Directeur/Bestuurslid bij Celleron Therapeutics Ltd.
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Declan Doogan | M | 72 |
Celleron Therapeutics Ltd.
Celleron Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Celleron Therapeutics Ltd. is an oncology company based in Oxford, UK. The company has deep relationships with Oxford University and is located on the Oxford Science Park. Celleron is focused on developing new and innovative therapies to treat cancer, with a particular emphasis on clinical development. The British company is developing a novel group of clinical products, supported by predictive companion diagnostics, that act through defined molecular mechanisms to prevent cancer cell growth. Celleron's lead products are in clinical trials, supported by a biomarker platform that allows responsive patients to be identified. The company was founded in 2004 and is led by CEO Nick la Thangue. | - |
David Kerr | M | - |
Celleron Therapeutics Ltd.
Celleron Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Celleron Therapeutics Ltd. is an oncology company based in Oxford, UK. The company has deep relationships with Oxford University and is located on the Oxford Science Park. Celleron is focused on developing new and innovative therapies to treat cancer, with a particular emphasis on clinical development. The British company is developing a novel group of clinical products, supported by predictive companion diagnostics, that act through defined molecular mechanisms to prevent cancer cell growth. Celleron's lead products are in clinical trials, supported by a biomarker platform that allows responsive patients to be identified. The company was founded in 2004 and is led by CEO Nick la Thangue. | - |
Nick la Thangue | M | - |
Celleron Therapeutics Ltd.
Celleron Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Celleron Therapeutics Ltd. is an oncology company based in Oxford, UK. The company has deep relationships with Oxford University and is located on the Oxford Science Park. Celleron is focused on developing new and innovative therapies to treat cancer, with a particular emphasis on clinical development. The British company is developing a novel group of clinical products, supported by predictive companion diagnostics, that act through defined molecular mechanisms to prevent cancer cell growth. Celleron's lead products are in clinical trials, supported by a biomarker platform that allows responsive patients to be identified. The company was founded in 2004 and is led by CEO Nick la Thangue. | - |
Robert Daniels | M | - |
Elastagen Pty Ltd.
Elastagen Pty Ltd. Medical SpecialtiesHealth Technology Elastagen Pty Ltd. produces and develops synthetic human elastin for medical device applications. Its products include skin rejuvenation, scar remodeling, skin tissue repair, wound healing, surgical glues and sealants. The firm developed a Elastatherapy treatments which offer the chance to restore the levels of Elastin in human skin, with benefits anticipated in both medical dermatology and cosmetic applications. The company was founded by Anthony Weiss in 2003 and is headquartered in Sydney, Australia. | - |
James Noble | M | 65 |
Celleron Therapeutics Ltd.
Celleron Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Celleron Therapeutics Ltd. is an oncology company based in Oxford, UK. The company has deep relationships with Oxford University and is located on the Oxford Science Park. Celleron is focused on developing new and innovative therapies to treat cancer, with a particular emphasis on clinical development. The British company is developing a novel group of clinical products, supported by predictive companion diagnostics, that act through defined molecular mechanisms to prevent cancer cell growth. Celleron's lead products are in clinical trials, supported by a biomarker platform that allows responsive patients to be identified. The company was founded in 2004 and is led by CEO Nick la Thangue. | - |
Yeong Un Bae | M | - |
KDB Infrastructure Investments Asset Management Co., Ltd.
KDB Infrastructure Investments Asset Management Co., Ltd. Investment ManagersFinance KDB Infrastructure Investments Asset Management Co., Ltd. (KIAMCO) is the private equity subsidiary of KDB Financial Group Inc, founded in 2003. The firm is headquartered in Seoul, South Korea. | - |
Moo-Jun Kim | M | - |
KDB Infrastructure Investments Asset Management Co., Ltd.
KDB Infrastructure Investments Asset Management Co., Ltd. Investment ManagersFinance KDB Infrastructure Investments Asset Management Co., Ltd. (KIAMCO) is the private equity subsidiary of KDB Financial Group Inc, founded in 2003. The firm is headquartered in Seoul, South Korea. | - |
Min-seop Lee | M | - |
KDB Infrastructure Investments Asset Management Co., Ltd.
KDB Infrastructure Investments Asset Management Co., Ltd. Investment ManagersFinance KDB Infrastructure Investments Asset Management Co., Ltd. (KIAMCO) is the private equity subsidiary of KDB Financial Group Inc, founded in 2003. The firm is headquartered in Seoul, South Korea. | - |
Jae-Sung Lee | M | - |
KDB Infrastructure Investments Asset Management Co., Ltd.
KDB Infrastructure Investments Asset Management Co., Ltd. Investment ManagersFinance KDB Infrastructure Investments Asset Management Co., Ltd. (KIAMCO) is the private equity subsidiary of KDB Financial Group Inc, founded in 2003. The firm is headquartered in Seoul, South Korea. | - |
In-Won Song | M | - |
KDB Infrastructure Investments Asset Management Co., Ltd.
KDB Infrastructure Investments Asset Management Co., Ltd. Investment ManagersFinance KDB Infrastructure Investments Asset Management Co., Ltd. (KIAMCO) is the private equity subsidiary of KDB Financial Group Inc, founded in 2003. The firm is headquartered in Seoul, South Korea. | - |
Collette Coll | M | - |
Celleron Therapeutics Ltd.
Celleron Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Celleron Therapeutics Ltd. is an oncology company based in Oxford, UK. The company has deep relationships with Oxford University and is located on the Oxford Science Park. Celleron is focused on developing new and innovative therapies to treat cancer, with a particular emphasis on clinical development. The British company is developing a novel group of clinical products, supported by predictive companion diagnostics, that act through defined molecular mechanisms to prevent cancer cell growth. Celleron's lead products are in clinical trials, supported by a biomarker platform that allows responsive patients to be identified. The company was founded in 2004 and is led by CEO Nick la Thangue. | - |
Sangwoo Lee | M | 52 |
Celleron Therapeutics Ltd.
Celleron Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Celleron Therapeutics Ltd. is an oncology company based in Oxford, UK. The company has deep relationships with Oxford University and is located on the Oxford Science Park. Celleron is focused on developing new and innovative therapies to treat cancer, with a particular emphasis on clinical development. The British company is developing a novel group of clinical products, supported by predictive companion diagnostics, that act through defined molecular mechanisms to prevent cancer cell growth. Celleron's lead products are in clinical trials, supported by a biomarker platform that allows responsive patients to be identified. The company was founded in 2004 and is led by CEO Nick la Thangue. | 8 jaar |
Jin-Young Son | M | - |
KDB Infrastructure Investments Asset Management Co., Ltd.
KDB Infrastructure Investments Asset Management Co., Ltd. Investment ManagersFinance KDB Infrastructure Investments Asset Management Co., Ltd. (KIAMCO) is the private equity subsidiary of KDB Financial Group Inc, founded in 2003. The firm is headquartered in Seoul, South Korea. | - |
John St. Clair Roberts | M | - |
Elastagen Pty Ltd.
Elastagen Pty Ltd. Medical SpecialtiesHealth Technology Elastagen Pty Ltd. produces and develops synthetic human elastin for medical device applications. Its products include skin rejuvenation, scar remodeling, skin tissue repair, wound healing, surgical glues and sealants. The firm developed a Elastatherapy treatments which offer the chance to restore the levels of Elastin in human skin, with benefits anticipated in both medical dermatology and cosmetic applications. The company was founded by Anthony Weiss in 2003 and is headquartered in Sydney, Australia. | - |
Michal Graff Mitzmacher | F | - |
Elastagen Pty Ltd.
Elastagen Pty Ltd. Medical SpecialtiesHealth Technology Elastagen Pty Ltd. produces and develops synthetic human elastin for medical device applications. Its products include skin rejuvenation, scar remodeling, skin tissue repair, wound healing, surgical glues and sealants. The firm developed a Elastatherapy treatments which offer the chance to restore the levels of Elastin in human skin, with benefits anticipated in both medical dermatology and cosmetic applications. The company was founded by Anthony Weiss in 2003 and is headquartered in Sydney, Australia. | - |
Kyunghwan Jang | M | - |
KDB Infrastructure Investments Asset Management Co., Ltd.
KDB Infrastructure Investments Asset Management Co., Ltd. Investment ManagersFinance KDB Infrastructure Investments Asset Management Co., Ltd. (KIAMCO) is the private equity subsidiary of KDB Financial Group Inc, founded in 2003. The firm is headquartered in Seoul, South Korea. | 16 jaar |
Byung-Hak Song | M | 61 |
KDB Infrastructure Investments Asset Management Co., Ltd.
KDB Infrastructure Investments Asset Management Co., Ltd. Investment ManagersFinance KDB Infrastructure Investments Asset Management Co., Ltd. (KIAMCO) is the private equity subsidiary of KDB Financial Group Inc, founded in 2003. The firm is headquartered in Seoul, South Korea. | 21 jaar |
Anthony Weiss | M | - |
Elastagen Pty Ltd.
Elastagen Pty Ltd. Medical SpecialtiesHealth Technology Elastagen Pty Ltd. produces and develops synthetic human elastin for medical device applications. Its products include skin rejuvenation, scar remodeling, skin tissue repair, wound healing, surgical glues and sealants. The firm developed a Elastatherapy treatments which offer the chance to restore the levels of Elastin in human skin, with benefits anticipated in both medical dermatology and cosmetic applications. The company was founded by Anthony Weiss in 2003 and is headquartered in Sydney, Australia. | 21 jaar |
Andrew Sneddon | M | 67 |
Elastagen Pty Ltd.
Elastagen Pty Ltd. Medical SpecialtiesHealth Technology Elastagen Pty Ltd. produces and develops synthetic human elastin for medical device applications. Its products include skin rejuvenation, scar remodeling, skin tissue repair, wound healing, surgical glues and sealants. The firm developed a Elastatherapy treatments which offer the chance to restore the levels of Elastin in human skin, with benefits anticipated in both medical dermatology and cosmetic applications. The company was founded by Anthony Weiss in 2003 and is headquartered in Sydney, Australia. | 16 jaar |
Stephen Thompson | M | - |
Elastagen Pty Ltd.
Elastagen Pty Ltd. Medical SpecialtiesHealth Technology Elastagen Pty Ltd. produces and develops synthetic human elastin for medical device applications. Its products include skin rejuvenation, scar remodeling, skin tissue repair, wound healing, surgical glues and sealants. The firm developed a Elastatherapy treatments which offer the chance to restore the levels of Elastin in human skin, with benefits anticipated in both medical dermatology and cosmetic applications. The company was founded by Anthony Weiss in 2003 and is headquartered in Sydney, Australia. | - |
Brigitte Smith | F | 56 |
Elastagen Pty Ltd.
Elastagen Pty Ltd. Medical SpecialtiesHealth Technology Elastagen Pty Ltd. produces and develops synthetic human elastin for medical device applications. Its products include skin rejuvenation, scar remodeling, skin tissue repair, wound healing, surgical glues and sealants. The firm developed a Elastatherapy treatments which offer the chance to restore the levels of Elastin in human skin, with benefits anticipated in both medical dermatology and cosmetic applications. The company was founded by Anthony Weiss in 2003 and is headquartered in Sydney, Australia. | - |
Xavier Yon | M | 84 |
Elastagen Pty Ltd.
Elastagen Pty Ltd. Medical SpecialtiesHealth Technology Elastagen Pty Ltd. produces and develops synthetic human elastin for medical device applications. Its products include skin rejuvenation, scar remodeling, skin tissue repair, wound healing, surgical glues and sealants. The firm developed a Elastatherapy treatments which offer the chance to restore the levels of Elastin in human skin, with benefits anticipated in both medical dermatology and cosmetic applications. The company was founded by Anthony Weiss in 2003 and is headquartered in Sydney, Australia. | - |
Richard Taylor | M | - |
Celleron Therapeutics Ltd.
Celleron Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Celleron Therapeutics Ltd. is an oncology company based in Oxford, UK. The company has deep relationships with Oxford University and is located on the Oxford Science Park. Celleron is focused on developing new and innovative therapies to treat cancer, with a particular emphasis on clinical development. The British company is developing a novel group of clinical products, supported by predictive companion diagnostics, that act through defined molecular mechanisms to prevent cancer cell growth. Celleron's lead products are in clinical trials, supported by a biomarker platform that allows responsive patients to be identified. The company was founded in 2004 and is led by CEO Nick la Thangue. | - |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Seong-Joon Lee | M | 70 |
KDB Infrastructure Investments Asset Management Co., Ltd.
KDB Infrastructure Investments Asset Management Co., Ltd. Investment ManagersFinance KDB Infrastructure Investments Asset Management Co., Ltd. (KIAMCO) is the private equity subsidiary of KDB Financial Group Inc, founded in 2003. The firm is headquartered in Seoul, South Korea. | - |
Sang-Ron Bae | M | - |
KDB Infrastructure Investments Asset Management Co., Ltd.
KDB Infrastructure Investments Asset Management Co., Ltd. Investment ManagersFinance KDB Infrastructure Investments Asset Management Co., Ltd. (KIAMCO) is the private equity subsidiary of KDB Financial Group Inc, founded in 2003. The firm is headquartered in Seoul, South Korea. | 6 jaar |
Hun Lee | M | 49 |
KDB Infrastructure Investments Asset Management Co., Ltd.
KDB Infrastructure Investments Asset Management Co., Ltd. Investment ManagersFinance KDB Infrastructure Investments Asset Management Co., Ltd. (KIAMCO) is the private equity subsidiary of KDB Financial Group Inc, founded in 2003. The firm is headquartered in Seoul, South Korea. | - |
Jung-Sun Choi | M | - |
KDB Infrastructure Investments Asset Management Co., Ltd.
KDB Infrastructure Investments Asset Management Co., Ltd. Investment ManagersFinance KDB Infrastructure Investments Asset Management Co., Ltd. (KIAMCO) is the private equity subsidiary of KDB Financial Group Inc, founded in 2003. The firm is headquartered in Seoul, South Korea. | 1 jaar |
Jae-Yong Song | M | - |
KDB Infrastructure Investments Asset Management Co., Ltd.
KDB Infrastructure Investments Asset Management Co., Ltd. Investment ManagersFinance KDB Infrastructure Investments Asset Management Co., Ltd. (KIAMCO) is the private equity subsidiary of KDB Financial Group Inc, founded in 2003. The firm is headquartered in Seoul, South Korea. | - |
Yanghee Lee | M | - |
KDB Infrastructure Investments Asset Management Co., Ltd.
KDB Infrastructure Investments Asset Management Co., Ltd. Investment ManagersFinance KDB Infrastructure Investments Asset Management Co., Ltd. (KIAMCO) is the private equity subsidiary of KDB Financial Group Inc, founded in 2003. The firm is headquartered in Seoul, South Korea. | - |
Hwajun Roh | M | - |
KDB Infrastructure Investments Asset Management Co., Ltd.
KDB Infrastructure Investments Asset Management Co., Ltd. Investment ManagersFinance KDB Infrastructure Investments Asset Management Co., Ltd. (KIAMCO) is the private equity subsidiary of KDB Financial Group Inc, founded in 2003. The firm is headquartered in Seoul, South Korea. | - |
Jae-Hyuk Jang | M | - |
KDB Infrastructure Investments Asset Management Co., Ltd.
KDB Infrastructure Investments Asset Management Co., Ltd. Investment ManagersFinance KDB Infrastructure Investments Asset Management Co., Ltd. (KIAMCO) is the private equity subsidiary of KDB Financial Group Inc, founded in 2003. The firm is headquartered in Seoul, South Korea. | - |
Hyuk-Jae Shin | M | - |
KDB Infrastructure Investments Asset Management Co., Ltd.
KDB Infrastructure Investments Asset Management Co., Ltd. Investment ManagersFinance KDB Infrastructure Investments Asset Management Co., Ltd. (KIAMCO) is the private equity subsidiary of KDB Financial Group Inc, founded in 2003. The firm is headquartered in Seoul, South Korea. | - |
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Zuid-Korea | 17 | 53.13% |
Australië | 8 | 25.00% |
Verenigd Koninkrijk | 7 | 21.88% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Sangwoon Lee
- Persoonlijk netwerk